跳至主要内容
临床试验/NCT04078685
NCT04078685Unknown不适用

Contact-Force-Sensing-Based Radiofrequency Catheter Ablation in Paroxysmal Supraventricular Tachycardias: a Randomized Controlled Trial

Erasmus Medical Center2 个研究点 分布在 1 个国家目标入组 113 人开始时间: 2018年6月12日最近更新:
适应症

试验速览

阶段
不适用
入组人数
113
试验地点
2
主要终点
Number of radiofrequency applications

研究概览

简要总结

The aim of this single-center prospective randomized controlled trial is to assess the superiority of contact-force-(CF)-sensing-based approach compared to conventional (non-CF-sensing) approach in the catheter ablation of PSVTs, and to investigate the safety of open-irrigated, contact-force-sensing ablation catheters (used in a "non-irrigated" mode) in these procedures.

详细描述

Rationale:

Multiple studies have demonstrated the importance of adequate catheter-tissue contact in the creation of effective lesions during radiofrequency catheter ablation. The development of contact-force(CF)-sensing catheters have contributed significantly to improve clinical outcomes in atrial fibrillation 3-18. However CF-sensing technology is not used in the ablation of paroxysmal supraventricular tachycardia. Although PSVT ablation with the conventional approach (non-irrigated, non-CF-sensing catheters) is considered a relatively low-risk procedure with fairly high success rate (short-and long-term) 1,2,19, we hypothesize that contact-force sensing can further improve the outcomes of these procedures. Based on the results of studies on atrial fibrillation ablation (mentioned above) we believe that CF-sensing could similarly improve such important parameters as radiofrequency (RF) application number/time, total procedure time, and fluoroscopy time in cases of PSVT ablations, as well. In addition CF-sensing could also further improve acute success/recurrence rates of PSVT ablation, and might also be capable to further diminish complication risk.

Primary Objective:

The primary objective of the present study is to demonstrate the superiority of contact-force-sensing in the ablation of AVNRT and WPW-AVRT as assessed by the improvement in the number and duration of radiofrequency applications compared with the conventional ablation approach.

Secondary Objective:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Referral for electrophysiology study because of pre-excitation on 12-lead surface ECG and/or documented (or suspected) symptomatic PSVT
  • Identification of AVNRT or WPW-AVRT (with manifest or concealed accessory pathway) during standard EP study
  • Verbal consent to continue with ablation therapy
  • Informed written consent to be included in the study

排除标准

  • evidence of structural heart disease and/or myocardial ischemia
  • pregnancy (and lack of exclusion of potential pregnancy)
  • age below 18 years

结局指标

主要结局

Number of radiofrequency applications

时间窗: From the beginning till the end of the ablation procedure

The number of radiofrequency applications during the ablation procedures of AVNRT and WPW-AVRT

次要结局

  • (Serious) Adverse Events(Till 12 months)
  • Overall duration of radiofrequency applications(From the beginning till the end of the ablation procedure)
  • Long-term procedural success(At 12 months)
  • Fluoroscopy time(From the beginning till the end of the ablation procedure)
  • Acute procedural success/failure(at the end of the ablation procedure)
  • Total duration of procedure(From the beginning till the end of the ablation procedure)
  • Time to recurrence of AVNRT/WPW-AVRT(up till 12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Tamás Géczy

Cardiologist

Erasmus Medical Center

研究点 (2)

Loading locations...

相似试验